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Abstract
The accumulation of DNA damage is thought to contribute to the physiological decay associated
with the aging process. Here, we report the results of a large-scale study examining longevity in
various mouse models defective in the repair of DNA alkylation damage, or defective in the DNA
damage response. We find that the repair of spontaneous DNA damage by alkyladenine DNA
glycosylase (Aag/Mpg)-initiated base excision repair and O6-methylguanine DNA
methyltransferase (Mgmt)-mediated direct reversal contributes to maximum life span in the
laboratory mouse. We also uncovered important genetic interactions between Aag, which excises
a wide variety of damaged DNA bases, and the DNA damage sensor and signaling protein, Atm.
We show that Atm plays a role in mediating survival in the face of both spontaneous and induced
DNA damage, and that Aag deficiency not only promotes overall survival, but also alters the
tumor spectrum in Atm−/− mice. Further, the reversal of spontaneous alkylation damage by Mgmt
interacts with the DNA mismatch repair pathway to modulate survival and tumor spectrum. Since
these aging studies were performed without treatment with DNA damaging agents, our results
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indicate that the DNA damage that is generated endogenously accumulates with age, and that
DNA alkylation repair proteins play a role in influencing longevity.
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1 INTRODUCTION
Aging can be thought of as a progressive decline in function at the cellular, tissue, and
organismal level, possibly resulting from cumulative damage to important biomolecules [1].
The reasons why we age and modulators of the aging process have been intensively studied
for decades (reviewed in [1]). One predominant but recently contested school of thought [2,
3], is described in the mitochondrial free radical theory of aging. In 1956, Harman first
proposed that mitochondrially-generated reactive oxygen and nitrogen species (RONS),
along with other harmful environmental physical and chemical agents, result in
accumulating damage in numerous biomolecules critical for proper cell function [4]. Genetic
experiments in various model organisms have pinpointed a variety of genes and pathways
that influence how an organism ages (reviewed in [5–8]); however, it has become clear that
additional random events also play an important role in the determination of longevity. In
fact, the accumulation of unrepaired DNA damage causing decreased genomic integrity, has
long been proposed as a major source of stochastic changes that can influence aging
(reviewed in [9, 10]). Accordingly, animals with genetic deficiencies in double-strand-break
repair or telomere maintenance have much shorter lifespans than wild-type (WT) mice [11,
12]. Further demonstrating the importance of unrepaired DNA damage in aging, mice or
patients carrying mutations in the transcription-coupled branch of nucleotide excision repair
(NER) suffer from a premature onset of aging-related symptoms and consequent shortening
of lifespan, but interestingly, with the exception of skin cancers, the decreased longevity
occurs in the absence of increased cancer development (reviewed in [13, 14][10]).
Inactivating mutations that disrupt the maintenance of genome stability can decrease
longevity through either increasing cancer predisposition or causing more general premature
aging and progeroid-like characteristics (reviewed in [10, 15, 16]). Indeed, multiple
important DNA damage response proteins were originally identified through the
investigation of cancer-prone patients. Cancer-prone Li-Fraumeni and ataxia telangiectasia
(AT) patients exhibit germline mutations in two important DNA damage response proteins,
namely p53 and ataxia telangiectasia mutated (ATM), respectively [17]. p53 (i.e., Trp53) is
a stress sensor and transcription factor responsible for inducing cell cycle checkpoints,
apoptosis or senescence upon exposure to DNA damage, hypoxia, and oncogene activation
among other stimuli; p53 was originally identified as a tumor suppressor and is known as the
“guardian” of the genome [17–19]. p53 also appears to have additional roles in modulating
aging, independent of its role in tumor suppression, presumably related to its role in cellular
senescence [17, 20]. ATM, an integral DNA damage signaling protein, is a serine/threonine
protein kinase that is activated in response to double-strand DNA breaks; ATM’s activation
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initiates important signaling pathways, some of which involve p53, responsible for cell cycle
checkpoint activation, apoptosis and DNA repair (reviewed in [21]).
DNA is exposed to a wide-range of damaging agents, not only from exogenous, but also
from endogenous sources. DNA base alkylation is one common consequence of multiple
endogenous metabolic processes (reviewed in [22]). For example, alkylation can occur as a
consequence of the non-enzymatic transfer of methyl groups to DNA from the universal
methyl donor, S-adenosylmethionine. Additionally, RONS, inevitable byproducts of aerobic
metabolism and also an important component of the innate immune response, are highly
reactive chemical species that produce numerous types of DNA damage. Furthermore,
RONS can indirectly induce alkylation DNA damage as a result of lipid peroxidation
reactions that generate reactive alkylating agents that react to produce etheno (ε) and other
DNA base adducts [23–27]. Livers of aged animals exhibit an accumulation of ε adducts,
specifically εA, suggesting a possible role for these lipid peroxidation reactions in aging
organisms [28]. DNA base lesions are also increased under conditions of chronic
inflammation, and are believed to contribute to the increased risk of carcinogenesis observed
in patients with chronic inflammation [29–32]. Therefore, various types of alkylation
damage arise in cells as a function of normal metabolic functions, and the role of such
endogenous DNA damage in influencing longevity has yet to be determined.
The pathways primarily responsible for the repair of alkylated DNA base lesions are base
excision repair (BER) and direct reversal (reviewed in [33].) BER is initiated when a
damaged DNA base is recognized and excised by a DNA glycosylase; alkyladenine DNA
glycosylase (Aag, a.k.a Mpg) recognizes numerous alkylated DNA base lesions, including
3-methyladenine (3meA) and 7-methylguanine (7meG) in mammals. Aag also recognizes
many lesions induced by RONS and lipid peroxidation products including hypoxanthine and
εA respectively [34–36]. Other alkylated DNA bases are subject to direct reversal repair,
either by oxidative demethylation catalyzed by the AlkB homolog (Alkbh) family of
proteins (reviewed in [33]), or by the efficient transfer of the unwanted methyl group on O6-
methylguanine (O6MeG) lesions to a cysteine residue in the O6MeG DNA methyltransferase
(Mgmt) in a suicide reaction [37]. Unrepaired O6MeG lesions pair with thymine during
replication. The mismatch repair (MMR) pathway recognizes O6MeG:thymine (O6MeG:T)
mismatches and subsequent MMR processing plays an essential role in alkylation-induced
cytotoxicity. MutSα, a heterodimer of Msh2 and Msh6 MMR proteins, recognizes
O6MeG:T mispairs, and this recognition is required for the induction of apoptosis [38–40].
The MMR pathway then engages in futile cycles of Exonuclease 1 (Exo1)-mediated
excision and DNA polymerase resynthesis at O6MeG:T mismatches, with excision and
reinsertion of the thymine opposite O6MeG; this results in persistent strand breaks that
ultimately culminate in the formation of double-strand DNA breaks at collapsed replication
forks (reviewed in [33, 37]). This alkylation hypersensitivity observed in the absence of
Mgmt is dependent on the presence of a functional MMR pathway [40–43].
The contribution of endogenous DNA alkylation damage to longevity has not been
rigorously examined. It is well-documented that Mgmt expression protects mice from
tumors induced by treatment with exogenous alkylating agents and therefore prolongs
survival following treatment with alkylating agents [44–47]. Intriguingly, transgenic
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C3HeB/FeJ male mice overexpressing Mgmt are protected against spontaneous
hepatocellular carcinomas in a susceptible mouse strain [48], suggesting a role for O6MeG
lesions in spontaneous tumors in a predisposed background and perhaps enhanced overall
survival. It has been more challenging to investigate the role for BER in longevity due to the
embryonic lethality observed upon deletion of many BER proteins [49–51]. However,
studies in heterozygous mice have provided insight into the importance of BER proteins in
modulating survival; for example, Polb+/− mice exhibit an acceleration in the age-dependent
mortality rate as well as increased tumorigenesis [52]. Finally, we and others have illustrated
the importance of Mgmt- and Aag-initiated DNA repair in chronic inflammation-associated
cancer, a frequent aging-associated phenomenon; Aag−/− and Mgmt−/− mice are more
susceptible to chronic inflammation-associated colon carcinogenesis [31, 32, 53, 54].
However, the contribution of Aag and Mgmt to overall longevity was, heretofore, not
specifically investigated.
Here we exploit mouse model systems to determine whether DNA alkylation repair proteins
acting on spontaneous DNA damage contribute to aging and longevity. We performed a
large-scale study to assess whether two major DNA alkylation repair pathways, namely
Aag-initiated BER and Mgmt-mediated direct reversal, promote longevity. Supplemental
Table 1 lists the mouse genotypes used in this study. We compared the longevity of Aag−/−,
Mgmt−/− and Aag−/−/Mgmt−/− mice with that of WT mice. We also investigated putative
genetic interactions that Aag and Mgmt might have with the DNA damage response
pathways controlled by p53 and Atm. Finally, because the MMR pathway is an important
modulator of cellular responses to O MeG, we investigated possible genetic interactions
between Mgmt and MMR by examining Mgmt −/−/Msh6 −/− and Mgmt −/−/Exo1 −/− mice.
Together, our comprehensive study illustrates that the repair of spontaneous DNA base
damage, likely to be primarily alkylation damage, influences the longevity of mice, and
provides information about potential interactions between DNA alkylation repair proteins
and downstream DNA damage response mediators.
2 RESULTS
2.1 Deficiency in alkylation repair alters long-term survival
Given that the endogenous generation of DNA damage is ubiquitous and continuous, we
determined whether repair of spontaneous DNA base damage, primarily alkylation damage,
contributes to longevity in mammals by assessing the long-term survival of mice deficient in
genes for the repair of alkylated DNA bases, i.e, Aag−/− and Mgmt−/− mice. Large cohorts of
WT, Aag−/−, Mgmt−/− and Aag−/−/Mgmt−/− mice were established and carefully monitored
for up to three years. Unlike mice deficient in NER [10, 14], none of the genotypes exhibited
any signs of premature aging. As mice became moribund, survival and histological data
were collected. Compared to WT mice, Aag−/− and Mgmt−/− mice exhibit a trend toward
decreased longevity, which did not reach statistical significance (Figure 1A). However, the
Aag−/−/Mgmt−/− animals display a significantly shorter life-span compared to WT (p=0.04);
the median survival of Aag−/−/Mgmt−/−mice was 89.5 weeks, more than 15 weeks shorter
than the median survival observed in WT mice (Figure 1A). These data indicate the
importance of repairing spontaneous DNA base lesions for attaining maximum longevity.
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The large-scale aging studies included detailed histopathological examination to identify
pathological features in the mice, including classification of any tumors, to determine
whether modulating DNA repair altered tumor incidence and/or tumor spectrum. In our
study, the most prevalent tumor type in WT, Aag−/−, Mgmt−/−, and Aag−/− /Mgmt−/− mice
was histiocytic sarcoma, a macrophage neoplasm and the most common tumor classification
in the C57Bl/6 strain [55]. We find that the absence of either Aag or Mgmt activity (or both)
did not significantly alter the tumor incidence or spectrum when compared to the WT mice
(Figure 1B); in other words, although the repair-deficient mice succumb earlier than WT, the
spectrum of disease and cause of death remains similar.
2.1 Influence of DNA damage response proteins on responses to endogenous DNA
alkylation damage
The p53 and Atm proteins are important stress mediators that respond to DNA damage.
Mice deficient in these proteins exhibit drastically reduced longevity, developing thymic
lymphoma within the first year of life [56, 57]. We sought to determine whether
accumulating unrepaired spontaneous DNA base damage (again, primarily alkylation
damage) may contribute to lymphomagenesis and diminished longevity in Atm−/− and
p53−/− mice. Although it is well established that Atm−/− mice exhibit significantly shortened
life spans [56, 58], detailed longevity, studies have not been reported for the C57Bl/6 strain
background. Figure 2A shows Kaplan-Meier survival curves for Atm−/− mice, both alone
and in combination with the Aag or Mgmt null alleles. Atm−/−, Aag−/−/Atm−/−, and
Mgmt−/−/Atm−/− mice all exhibit decreased survival when compared to the WT mice (all
pair-wise comparisons to wild type, p<0.0001). However, in contrast to previous studies in
mixed background mice, we find that Atm−/− C57Bl/6 mice survive significantly longer than
Atm−/− mixed background mice [56, 58]. In fact, in our aging study, 20% of Atm−/− C57Bl/6
mice survive longer than one year (Figure 2A), whereas most Atm−/− mice on a mixed
background succumbed to thymic lymphoma by 4.5 months [56, 58]. We find that the
addition of the Mgmt null allele does not significantly change the survival of Atm−/− animals
(p=0.3423), suggesting that endogenously formed O6MeG lesions are not determinants of
survival in Atm−/− mice. Surprisingly, Aag−/−/Atm−/− C57Bl/6 mice live significantly longer
than Atm −/− C57Bl/6 mice (pair-wise comparison between Atm−/− and Aag−/−/Atm−/−,
p=0.0193) (Figure 2A). These results indicate that, in contrast to Aag-mediated repair of
endogenous DNA base damage extending longevity, Aag activity in Atm−/− mice actually
decreases longevity. This counterintuitive finding is considered further in the discussion.
We also monitored disease incidence and tumor spectrum in the aged Atm−/−, Mgmt−/−/
Atm−/− or Aag−/−/Atm−/− mice; Figure 2B shows the incidence of spontaneous pathology.
WT, Mgmt−/− and Aag−/− mice exhibit a remarkably similar spectrum of tumors, but this
spectrum is significantly different from that in the Atm deficient genotypes (Atm−/−,
Mgmt−/−/Atm−/−, and Aag−/−/Atm−/−) that exhibit a predominance of lymphoma [56, 58];
94% of the Atm−/− mice in our study presented with lymphomas at the time of death.
Aag−/−/Atm−/− animals exhibit a decreased incidence of lymphoma (70%), and the overall
difference in tumor spectrum between Atm−/− and Aag−/−/Atm−/− mice is statistically
significant (p<0.016). This suggests that one mechanism by which Aag deficiency increases
longevity in Atm−/− animals may be by decreasing the development of aggressive
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lymphomas. Although Mgmt−/−/Atm−/− also display a decrease in lymphoma incidence
(71.5%), it did not alter the overall tumor spectrum (p=0.19) (Figure 2B) or longevity
(Figure 1B), suggesting that the tumors that arose instead of lymphoma in Mgmt−/−/Atm−/−
mice were as aggressive as lymphoma.
Detailed survival studies have been published for p53−/− mice [57], and here we set out to
determine whether decreased repair of primarily alkylated DNA bases would affect
longevity in p53−/− mice. In stark contrast to the effect of combining Aag−/− or Mgmt−/−
with the Atm−/− genotype, we observe virtually identical survival in p53−/−, Aag−/−/p53−/−,
and Mgmt−/−/p53−/− mice; all three genotypes exhibited significant and similarly-decreased
survival compared to WT mice (p<0.0001) (Figure 3A). All p53 deficient genotypes
exhibited an altered tumor spectrum compared to WT mice, but there was no difference in
tumor spectrum between p53−/−, Aag−/−/p53−/−, and Mgmt−/−/p53−/− mice (Figure 3B).
2.3 Genetic interaction between Mgmt and the MMR pathway
Given the established link between Mgmt and MMR in modulating alkylation-induced
cytotoxicity [37, 40, 41, 59, 60], we investigated whether deficiency of both Mgmt and
MMR proteins may cooperate to alter longevity. The effect of eliminating mismatch
recognition and excisions steps of MMR in combination with Mgmt was investigated. As
described, Mgmt deficiency does not significantly alter long-term survival in vivo (Figure
1A). Figure 4A presents survival data for WT, Mgmt−/−, Msh6−/−, Exo1−/−, Mgmt−/−/
Msh6−/− and Mgmt−/−/Exo1−/− mice. Similar to previous reports, we observe significantly
decreased survival in Msh6−/− and Exo1−/−mice compared to WT mice (p<0.0001) [61, 62].
We observed a trend toward increased longevity in Mgmt−/−/Msh6−/−, which did not reach
statistical significance (pairwise comparison between Msh6−/−and Mgmt−/− Msh6−/−,
p<0.3388). Similarly, the trend toward increased survival in Mgmt−/−/Exo1−/− versus
Exo1−/− mice did not reach statistical significance (pairwise comparison between
Exo1−/−and Mgmt−/− Exo1−/−, p=0.1352) (Figure 4A). We infer that Mgmt substrates do not
significantly impact whole-animal survival, even in the absence of functional MMR.
Although a genetic interaction was observed between Mgmt and Msh6 or Exo1 in terms of
mediating alkylation cytotoxicity upon treatment with exogenous alkylating agents in vivo
[63], this does not appear to translate to effects from endogenous alkylation arising in vivo.
Detailed histological examination of the aged animals showed that the trends toward
increased survival were accompanied by differences in pathology. Figure 4B shows the
incidence of spontaneous pathology in animals with combinations of the Mgmt null allele
with either Msh6 or Exo1 null alleles, namely Mgmt−/−, Msh6−/−, Exo1−/−, Mgmt−/−/
Msh6−/−, and Mgmt−/−/Exo1−/− mice. The majority of the MMR defective animals exhibit
lymphomas at the time of death; 70% of Msh6−/−animals and 70.5% of Exo1−/− animals
present with lymphoma, consistent with the published literature (Figure 4B) [61, 62]. The
additional inactivation of the Mgmt gene does not significantly alter the tumor spectrum in
Msh6 mutant background; 73% of Mgmt−/−/Msh6−/− mice develop lymphoma (Figure 4B).
Remarkably, Mgmt deficiency results in a greater than 50% reduction in the incidence of
lymphoma in Exo1−/− mice; 70.5% in Exo1−/− mice develop lymphoma whereas only 31%
of Mgmt−/− /Exo1−/− mice present with this pathology. The reduction of lymphoma in
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Mgmt−/− /Exo1−/− mice coincides with a two-fold increase in histiocytic sarcoma, the
predominant pathology observed in Mgmt−/− mice. The change in tumor spectrum between
the Exo1−/− and the Mgmt−/−/Exo1−/− is significant (p=0.03).
2.4 The contribution of Atm to cellular responses following exogenous DNA alkylation
damage
Aag deficiency resulted in a counter-intuitive increase in longevity in Atm−/− deficient mice,
accompanied by alterations in the tumor spectrum (Figures 2A and 2B). To further examine
this genetic interaction between Atm and Aag, we used the tractable bone marrow (BM) ex
vivo clonogenic survival assay to determine whether, as seems to be the case for endogenous
DNA damage, Atm modulates Aag-mediated alkylation-induced cytotoxicity. BM cells were
treated ex vivo with the alkylating agent methyl methane sulfonate (MMS) and then plated
on semisolid media to allow formation of hematopoietic myeloid progenitor colonies. MMS
is an SN2 alkylating agent that induces predominantly 7MeG and 3MeA DNA lesions,
known Aag substrates [34]. Consistent with a previous report [64], we show here that Aag−/−
BM cells are resistant to MMS (Figure 5). This is consistent with multiple recent reports
showing that initiation of BER by DNA glycosylases generates repair intermediates (AP-
sites, and single-strand breaks (SSBs)) that, if accumulate due to downstream BER enzymes
being limited, are more toxic than the original DNA base lesions (reviewed in [33]). This is
supported by evidence indicating that alkylation sensitivity is dependent on Aag-initiated
BER both in cultured cells and in animals [65–67]. Interestingly, Atm−/− BM cells display
increased MMS sensitivity in comparison to all other genotypes, indicating that Atm
signaling is an important mediator of MMS-mediated toxicity. The increased sensitivity
observed in Atm−/− BM cells is almost totally suppressed in Aag−/−/Atm−/− BM cells,
suggesting that much of the alkylation sensitivity observed in the Atm−/− cells is due to Aag-
initiated BER of MMS-induced base damage followed by the accumulation of toxic BER
intermediates that are ultimately sensed by Atm (Figure 5A). Together, these ex vivo assays
illustrate that Atm is an integral modulator of toxicity induced by Aag-initiated BER, and
pinpoints a role for the Atm DNA damage response protein in signaling downstream of toxic
BER intermediates.
We also assessed the contribution of Atm to O6meG-mediated cytotoxicity following
exposure to the SN1 alkylating agent, N-methyl-N-nitrosourea (MNU), which generates
toxic and mutagenic O6MeG, in addition to 7meG and 3meA DNA base lesions. Ex vivo
clonogenic survival assays were performed with BM from WT, Mgmt−/−, Atm−/− and
Mgmt−/−/Atm−/−mice. In contrast to MMS, Atm−/− BM cells exhibit no difference in MNU
sensitivity compared to WT cells at the doses used (Figure 5B), presumably because both
WT and Atm−/− cells express Mgmt to reverse the toxic
O6meG lesions. Accordingly, Mgmt−/− cells exhibit increased sensitivity to MNU compared
to both WT and Atm−/− cells. Strikingly, we observe a massively synergistic interaction
between Mgmt and Atm; Mgmt−/−/Atm−/− cells exhibit dramatically increased sensitivity to
MNU when compared to Mgmt−/− or Atm−/− cells (Figure 5B). We infer that when O6MeG
base lesions are unrepaired (as in the Mgmt−/− cells), Atm plays a pivotal role in modulating
the toxicity induced by MMR processing of DNA containing O6MeG DNA lesions.
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3 DISCUSSION
Here we describe a large-scale aging study of numerous mouse models defective in several
DNA repair genes and DNA damage response genes (Supplemental Table 1). Essential for a
study of this magnitude, all animals were backcrossed to the C57Bl/6 genetic background
for at least 10 generations to ensure that any differences observed could not be attributed to
differences in strain background.
Accumulating toxic and mutagenic damage in mitochondrial and nuclear DNA is known to
affect the aging process in model organisms [68–71]. We show here that endogenously
damaged DNA bases that are substrates for two DNA alkylation repair pathways contribute
to long-term survival; mice deficient in both Aag and Mgmt activity exhibit decreased life-
span that is statistically significant. The accumulation of unrepaired DNA damage and
mutations associated with aging may simply arise due to long-term exposure to endogenous
metabolites that damage DNA, and may be exacerbated by an age-related decline in the
DNA repair capacity. The capacity to perform BER, NER and double-strand break (DSB)
repair have, in fact, all been shown to decline with age (reviewed in [72–74]). Further,
studies in mice indicate that certain tissues or anatomical sites may be more susceptible to
such age-related DNA repair decline [69] perhaps due to differing exposure to RONS [75,
76]. All of these possibilities are not necessarily mutually exclusive and likely cooperate as
contributing factors in influencing longevity. Indeed, in the worst case scenario, aging
tissues could have both decreased DNA repair and DNA damage responses accompanied by
increased levels of endogenous metabolites that damage DNA.
We and others have demonstrated that for certain cell types Aag-mediated initiation of BER
can lead to cell death, and that Aag deficiency can actually be protective [65, 66]. Here, we
find that Aag deficiency protects Atm−/− mice both in terms of increasing overall longevity
and in reducing the development of lymphoma; this protection is consistent with a role for
Aag in generating toxic BER intermediates that trigger the DNA damage response
orchestrated by Atm. Further, Aag deficiency provided protection against MMS-induced
toxicity in Atm−/− BM cells, ex vivo. Together, this indicates that Atm is required for
protection against Aag-mediated alkylation-induced toxicity, and that endogenously-
generated Aag substrates can influence organismal longevity. This may not be surprising
given that Aag acts on a wide range of endogenously-generated base lesions including
7meG, 3meA, deaminated adenine, oxidized guanine and etheno-base lesions [26, 34, 77,
78]. A link between Atm and BER has been implicated in numerous reports [79–81], but the
data here provide in vivo evidence that Atm plays a key role in protecting against the
detrimental effects of Aag-mediated BER intermediate formation at sites of spontaneous
DNA base damage.
Interestingly, although ATM is known to phosphorylate, stabilize and activate p53 [82],
there is no change in survival in Aag−/−/p53−/− mice, in contrast to enhanced survival in
Aag−/−/Atm−/− mice. The protection in Aag−/−/Atm−/− mice compared to Aag−/−/p53−/− mice
may be explained by the numerous p53-independent functions of Atm [82]. Alternatively, it
has been shown previously that Aag physically interacts with and represses p53 [83];
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therefore genetic deletion of both Aag and p53 would be epistatic and not alter overall
survival compared to p53−/− mice.
Mgmt deficiency does not affect survival or tumor spectrum in Atm−/− mice. However, a
clear genetic interaction between Mgmt and Atm was observed in the ex vivo BM
clonogenic survival assays. Predictably, Mgmt−/− BM cells exhibit alkylation
hypersensitivity but surprisingly, Mgmt−/−/Atm−/− BM cells exhibit a synergistic increase in
alkylation sensitivity. We propose that in the absence of Mgmt, futile cycling of MMR at
O6meG:T mispairs results in the generation of DSBs that activate Atm [83–86]. Without
Atm and Mgmt, MMR-mediated futile cycling continues without the Atm-mediated
signaling pathways, further exacerbating cell death. Together, this illustrates that Atm
contributes to the cellular response to O6meG induced by exogenous alkylating agents, but
implies that spontaneous O6meG lesions are not relevant in the development of morbidity in
Atm−/−/Mgmt−/− mice, although it is possible that the decreased lifespan of Atm−/− mice
precludes any potential cumulative detrimental effects of endogenous O6meG lesions in
Atm−/−/Mgmt−/− mice.
It is intriguing that Mgmt deficiency protected Exo1−/− mice against the development of
lymphoma; instead Mgmt−/−/Exo1−/− mice developed histiocytic sarcoma, the prevalent
disease in C57Bl/6 mice. Although Mgmt−/−/Exo1−/− mice exhibited decreased incidence of
lymphoma, there was only a trend toward increased longevity, indicating that the protection
against lymphoma and the overall shift in tumor spectrum did not prolong lifespan. Mgmt−/−
mice develop histiocytic sarcoma at an average latency of 25.5 months, whereas in Mgmt−/−/
Exo1−/− mice, the onset of histiocytic sarcoma is significantly earlier (p=0.0035), with an
average latency of 21.7 months. Although Mgmt deficiency altered tumor penetrance in
Exo1−/− mice, this was not observed in Msh6−/− mice. Msh6 deficiency results in a strong
predisposition to lymphomagenesis, which occurs significantly earlier than in Exo1−/− mice
(p=0.0002). The constitutive MMR deficiency (CMMRD) cancer syndrome in humans
substantiates the role for Msh6 in preventing hematological malignancies and other cancers
[87–89] and reinforces the finding that Msh6 deficiency is a strong inducer of lymphoma in
mice [61]. EXO1 deficiency is not causative of CMMRD, but EXO1 mutations have been
found in diffuse B-cell lymphoma [87]. The strong association between MSH6 mutations
and lymphoma may explain why Mgmt deficiency was insufficient to change tumor
spectrum in Msh6−/− mice, whereas Mgmt−/−/Exo1−/− mice exhibited a shift in tumor
spectrum towards histiocytic sarcoma.
Although the link between accumulating DNA damage and aging has been clearly
established, the consequences of lifestyle interventions that increase longevity and their role
on altering DNA repair capacity remain unresolved. One proven strategy demonstrated to
enhance longevity is calorie restriction (CR); the consequence of CR on DNA repair remains
controversial. CR has been shown to reduce the age-dependent decline in non-homologous
end joining activity [90], whereas other studies show a decrease in DNA repair transcript
levels following CR [91]. Additionally, it is well-known that habitual endurance exercise
improves health-span [92, 93], and although endurance exercise is associated with an
increase in oxidative DNA damage [94], exercise-induced RONS are thought to induce
DNA repair and other molecular systems to cope with increased RONS damage [95–98].
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Finally, resveratrol, a polyphenol found in red wine and an activator of the NAD-dependent
deacetylase sirtuin-1 (Sirt1), has been hypothesised to increase longevity. Resveratrol
increases the formation of APE/XRCC1 complex during BER [99], but also reduces the
activity or expression of other DNA repair proteins [100, 101]. These few examples
underscore the fact that much remains to be learned regarding the relationship between DNA
repair and lifestyle interventions that may modulate longevity.
Significant progress has been made regarding the pathways and factors that modulate
longevity [1, 102, 103], and yet many questions remain unanswered. Several theories of
aging have been proposed including: the mitochondrial free radical theory of aging, telomere
attrition, mitochondrial dysfunction, and more recently, the functional decline of stem cells
(aging theories reviewed in [104–106]). It is likely that many of the proposed mechanisms of
aging interact with each other to influence the longevity of an organism. Here, using long-
term lifespan studies in DNA repair- and DNA damage-response deficient mouse models,
we establish that the repair of DNA base alkylation damage arising from endogenous
sources is at least one contributing factor to longevity.
4 METHODS
4.1 Mice
The Aag−/− mice [107] and Mgmt−/− mice [108] have been described. Trp53−/− mice
(B6.129S2-Trp53tm1Tyj, former name C57BL/6J-Trp53tm1Tyj) and Atm−/− mice (129S6/
SvEvTac-Atmtm1Awb/J) were purchased from The Jackson Laboratory (Bar Harbor, Maine,
USA). Exo1−/− and Msh6−/− mice have been described previously [61, 62]. All mice were
backcrossed at least 10 times to the C57BL/6 background. Mice were fed standard diet ad
libitum and housed in an AAALAC accredited facility. Animals were sacrificed by CO2
asphyxiation. All animal procedures were approved by the MIT Committee on Animal Care.
4.2 Longevity studies
Mice were allowed to age and observed for development of disease and subject to full
necropsy when diseased or deceased. Tissues were fixed in Bouin’s fixative, paraffin
embedded, sectioned at 5 µm and stained with haematoxylin and eosin (H&E). Tissues
harvested include: brain, eyes, salivary gland, thymus, heart, lung, liver, kidney, spleen,
intestine, reproductive organs, and femur. All H&E stained slides were analyzed blind by a
pathologist (R.T.B) for the cause of death as well as for identification of any tumors/lesions.
Examples of lesions classified as other include: dermatitis, cystic endometrium/uterus,
emphysema, kidney disease and osteoarthritis.
4.3 Bone marrow clonogenic survival assay
BM clonogenic survival assays were performed as described in [64]. Briefly, cells were
harvested from the femurs of mice, treated ex vivo with MMS (Sigma-Aldrich Co, St. Louis,
MO) or MNU (Sigma-Aldrich Co, St. Louis, MO) and plated in methylcellulose-containing
media (Stem Cell Technologies, Vancouver, BC, Canada), and plated in duplicate. After
approximately 2 weeks, colonies containing > 50 cells were scored. Experiments were
performed at least three times.
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4.4 Statistical analysis
GraphPad Prism was used to generate Kaplan-Meier plots for survival and to calculate
significance using Log-rank (Mantel-Cox) test. Fisher’s exact, programmed in R, was used
to establish whether the differences in tumor spectra between genotypes were significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
Large-scale mouse aging study examines role for DNA repair and DNA damage
response.
Repair of endogenous alkylation damage plays a role in determining longevity.
Atm plays a key role in protecting against detrimental effects of Aag-mediated BER.
Meira et al. Page 18
DNA Repair (Amst). Author manuscript; available in PMC 2015 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. DNA alkylation repair contributes to longevity
A) Survival curves of wild type (black lines, n=37), Aag−/− (red line, n=29), Mgmt−/− (blue
line, n=50) and Aag−/− Mgmt−/− (purple line, n=31). Pair-wise comparisons: Aag−/− to wild
type, p=0.1003; Mgmt−/− to wild type, p=0.4752; Aag−/− Mgmt−/− to wild type, p=0.04, all
Log-rank (Mantel-Cox) test. B) Histopathological classification of pathologies found in WT
(n=18), Aag−/− (n=24), Mgmt−/− (n=35), and Aag−/− Mgmt−/− (n=31) mice.
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Figure 2. Atm plays a role in the response to endogenous/spontaneous DNA alkylation damage
A) Survival curves of wild type (black lines, n=37), Atm−/− (green line, n=19), Aag−/−
Atm−/− (green/red line, n=22) and Mgmt−/− Atm−/− (cyan line, n=21). All pair-wise
comparisons to wild type, p<0.0001. Pair-wise comparison between Atm−/− and Aag−/−
Atm−/−, p=0.0193, and between Atm−/− and Mgmt−/− Atm−/−, p=0.3423, all comparisons
Log-rank (Mantel-Cox) test. B) Aag deficiency protects against lymphoma in Atm−/−
animals. Graph shows the incidence of age-related pathologies observed in Aag and Atm
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genotypic combinations. Wild-type (n=18); Aag−/− (n=24); Mgmt−/− (n=35); Atm−/− (n=15);
Mgmt−/− Atm−/− (n=7); Aag−/− Atm−/− (n=10).
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Figure 3. Aag and Mgmt mutations do not affect longevity of p53 mutant animals
A) Survival curves of wild type (black lines, n=37), p53−/− (light green line, n=21), Aag−/−
p53−/− (light red line, n=42), and Mgmt−/− p53−/− (light blue line, n=18). All pair-wise
comparisons to wild type, p<0.0001, Log-rank (Mantel-Cox) test. B) Aag or Mgmt
deficiency does not shift tumor spectrum in p53−/− mice. Graph shows the incidence of age-
related pathologies observed in Aag and p53 genotypic combinations. Wild-type (n=18);
p53−/− (n=8); Aag−/− p53−/− (n=14); Mgmt−/− p53−/− (n=9).
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Figure 4. Interaction between Mgmt deficiency and the mismatch repair pathway
Survival curves of wild type (black lines, n=37), Mgmt−/− (blue line, n=50), Exo1−/− (purple
line, n=19), Mgmt−/− Exo1−/− (dashed lilac line, n=30), Msh6−/− (orange line, n=10), and
Mgmt−/− Msh6−/− (dashed light orange line, n=19). Pair-wise comparison between Mgmt−/−
and Mgmt−/− Exo1−/−, p=0.0008 and between Mgmt−/− and Mgmt−/− Msh6−/−, p<0.0001,
Log-rank (Mantel-Cox) test. B) The Mgmt null mutation leads to a decrease in the incidence
of lymphomas in Exo1−/− animals but not in Msh6−/− animals. Wild-type (n=18); Mgmt−/−
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(n=33), Exo1−/− (n=17), Msh6−/− (n=10), Mgmt−/− Msh6−/− (n=19), Mgmt−/− Exo1−/−
(n=29).
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Figure 5. Atm and Aag interact in response to induced alkylation damage
A) Ex vivo alkylation sensitivity of BM cells to methyl methanesulfonate (MMS). BM cells
were derived from wild type (closed squares), Aag−/− (closed triangle), Atm−/− (open
squares) and Aag−/− Atm−/− (open triangle) mice. Experiments were done a minimum of
three times each, data are mean ± SEM.. B) Synergistic interaction between Mgmt and Atm
in response to MNU treatment. Ex vivo alkylation sensitivity of BM cells to methyl
nitrosourea (MNU). BM cells were derived from wild type (closed squares), Mgmt−/−
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(closed circles), Atm−/− (open squares) and Mgmt−/− Atm−/− (open circles) mice.
Experiments were done a minimum of three times each, data are mean ± SEM.
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Table 1
Median survival of all mice, median survival of mice with tumors, and tumor penetrance in aging study.
Genotype
Median
Survival,
weeks
Median
Survival
(tumor),
weeks
% tumor at
termination
Wildtype 106 98 61.1
Aag−/− 94 99 54.2
Mgmt−/− 99.5 103.5 57.1
Atm−/− 29 35 100
p53−/− 20 21.5 100
Exo1−/− 81 82.3 94.1
Msh6−/− 26.5 25 100
Aag−/−Mgmt−/− 89.5 94.5 58
Aag−/−Atm−/− 44 63 90
Aag−/−p53−/− 20 22 92.8
Mgmt−/−Atm−/− 40 49 100
Mgmt−/−p53−/− 20.5 22 100
Mgmt−/−Exo1−/− 91.5 92 96.5
Mgmt−/−Msh6−/− 45 45 100
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